Although pre-exposure prophylaxis (PrEP) requires a prescription from a health care provider, we lack unanimity in guidelines for the identification of the ideal provider type to prescribe PrEP. The purpose of our study was to understand clinician perspectives on provider categories to determine who is best suited to prescribe this medication to HIV-uninfected patients. We conducted 28 in-depth interviews between September 2017 and January 2018 with current prescribers of PrEP. Qualitative findings indicated that providers were split on recommended PrEP prescriber type. Five themes emerged that centered on the explicit identification of the issue of opportunity for providers to educate their patients on PrEP and offer this medication to at-risk populations. To effectively maximize presentation for care and subsequently amplify uptake of PrEP, growing the base of providers who offer PrEP to eligible patients can provide a meaningful public health impact on reducing HIV incidence.
Sarahmona Przybyla, PhD, MPH, is an Assistant Professor, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York, USA. Susan LaValley, PhD, is a Research Assistant Professor, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA. Noelle St. Vil, PhD, is an Assistant Professor, School of Social Work, University at Buffalo, Buffalo, New York, USA.
Corresponding author: Sarahmona Przybyla, e-mail: email@example.com
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.